keyword
https://read.qxmd.com/read/38584528/knockdown-of-ubiquitin-conjugating-enzyme-e2-t-abolishes-the-progression-of-head-and-neck-squamous-cell-carcinoma-by-inhibiting-nf-%C3%AE-b-signaling-and-inducing-ferroptosis
#1
JOURNAL ARTICLE
Feng Cai, Hongbo Xu, Shilong Song, Gengming Wang, Yajun Zhang, Jing Qian, Lu Xu
BACKGROUND: Ubiquitin-conjugating enzyme 2T (UBE2T) has been reported to be associated with uncontrolled cell growth and tumorigenesis in multiple cancer types. However, the understanding of its regulatory role in the carcinogenesis of Head And Neck Squamous Cell Carcinoma (HNSC) is limited. METHODS: UBE2T expression in HNSC patient samples and the correlation between its expression and patients' survival rates were evaluated using The Cancer Genome Atlas (TCGA) database...
April 4, 2024: Current Protein & Peptide Science
https://read.qxmd.com/read/38358126/identification-of-small-molecule-binding-sites-of-a-ubiquitin-conjugating-enzyme-ube2t-through-fragment-based-screening
#2
JOURNAL ARTICLE
Yong Yao Loh, Jothi Anantharajan, Qiwei Huang, Weijun Xu, Justina Fulwood, Hui Qi Ng, Elizabeth Yihui Ng, Chong Yu Gea, Meng Ling Choong, Qian Wen Tan, Xiaoying Koh, Wan Hsin Lim, Kassoum Nacro, Joseph Cherian, Nithya Baburajendran, Zhiyuan Ke, CongBao Kang
UBE2T is an attractive target for drug development due to its linkage with several types of cancers. However, the druggability of ubiquitin-conjugating E2 (UBE2T) is low because of the lack of a deep and hydrophobic pocket capable of forming strong binding interactions with drug-like small molecules. Here, we performed fragment screening using 19 F-nuclear magnetic resonance (NMR) and validated the hits with 1 H-15 N-heteronuclear single quantum coherence (HSQC) experiment and X-ray crystallographic studies...
March 2024: Protein Science
https://read.qxmd.com/read/38243224/circnup50-is-a-novel-therapeutic-target-that-promotes-cisplatin-resistance-in-ovarian-cancer-by-modulating-p53-ubiquitination
#3
JOURNAL ARTICLE
Yunshu Zhu, Leilei Liang, Yuxi Zhao, Jian Li, Jia Zeng, Yihang Yuan, Ning Li, Lingying Wu
BACKGROUND: Most patients with ovarian cancer (OC) treated with platinum-based chemotherapy have a dismal prognosis owing to drug resistance. However, the regulatory mechanisms of circular RNA (circRNA) and p53 ubiquitination are unknown in platinum-resistant OC. We aimed to identify circRNAs associated with platinum-resistant OC to develop a novel treatment strategy. METHODS: Platinum-resistant circRNAs were screened through circRNA sequencing and validated using quantitative reverse-transcription PCR in OC cells and tissues...
January 19, 2024: Journal of Nanobiotechnology
https://read.qxmd.com/read/38216092/identification-of-mcm4-and-prkdc-as-new-regulators-of-osteosarcoma-cell-dormancy-based-on-3d-cell-cultures
#4
JOURNAL ARTICLE
Camille Jubelin, Javier Muñoz-Garcia, Emilie Ollivier, Denis Cochonneau, François Vallette, Marie-Françoise Heymann, Lisa Oliver, Dominique Heymann
Dormancy is a potential way for tumors to develop drug resistance and escape treatment. However, the mechanisms involved in cancer dormancy remain poorly understood. This is mainly because there is no in vitro culture model making it possible to spontaneously induce dormancy. In this context, the present work proposes the use of three-dimensional (3D) spheroids developed from osteosarcoma cell lines as a relevant model for studying cancer dormancy. MNNG-HOS, SaOS-2, 143B, MG-63, U2OS and SJSA-1 cell lines were cultured in 3D using the Liquid Overlay Technique (LOT)...
January 10, 2024: Biochimica et Biophysica Acta. Molecular Cell Research
https://read.qxmd.com/read/37979329/identification-and-characterization-of-inhibitors-covalently-modifying-catalytic-cysteine-of-ube2t-and-blocking-ubiquitin-transfer
#5
JOURNAL ARTICLE
Jothi Anantharajan, Qian Wen Tan, Justina Fulwood, Wang Sifang, Qiwei Huang, Hui Qi Ng, Xiaoying Koh, Weijun Xu, Joseph Cherian, Nithya Baburajendran, CongBao Kang, Zhiyuan Ke
UBE2T is an E2 ubiquitin ligase critical for ubiquitination of substrate and plays important roles in many diseases. Despite the important function, UBE2T is considered as an undruggable target due to lack of a pocket for binding to small molecules with satisfied properties for clinical applications. To develop potent and specific UBE2T inhibitors, we adopted a high-throughput screening assay and two compounds-ETC-6152 and ETC-9004 containing a sulfone tetrazole scaffold were identified. Solution NMR study demonstrated the direct interactions between UBE2T and compounds in solution...
November 11, 2023: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/37958210/cancer-metastasis-prediction-and-genomic-biomarker-identification-through-machine-learning-and-explainable-artificial-intelligence-in-breast-cancer-research
#6
JOURNAL ARTICLE
Burak Yagin, Fatma Hilal Yagin, Cemil Colak, Feyza Inceoglu, Seifedine Kadry, Jungeun Kim
AIM: Method: This research presents a model combining machine learning (ML) techniques and eXplainable artificial intelligence (XAI) to predict breast cancer (BC) metastasis and reveal important genomic biomarkers in metastasis patients. METHOD: A total of 98 primary BC samples was analyzed, comprising 34 samples from patients who developed distant metastases within a 5-year follow-up period and 44 samples from patients who remained disease-free for at least 5 years after diagnosis...
October 26, 2023: Diagnostics
https://read.qxmd.com/read/37773242/backbone-1-h-15-n-and-13-c-resonance-assignments-for-an-e2-ubiquitin-conjugating-enzyme-ube2t
#7
JOURNAL ARTICLE
Qiwei Huang, Hui Qi Ng, Yong Yao Loh, Zhiyuan Ke, Wan Hsin Lim, CongBao Kang
Ubiquitin-conjugating enzyme E2 T (UBE2T) plays important roles in ubiquitination of proteins through participation in transferring ubiquitin to its substrate. Due to its importance in protein modifications, UBE2T associates with diverse diseases and serves as an important target for drug discovery and development. The crystal structure of UBE2T has been determined and the structure reveals the lack of a druggable pocket for binding to small molecules for clinical applications. Despite the challenge, effort has been made to develop UBE2T inhibitors...
September 29, 2023: Biomolecular NMR Assignments
https://read.qxmd.com/read/37732274/the-fanconi-anemia-core-complex-promotes-ctip-dependent-end-resection-to-drive-homologous-recombination-at-dna-double-strand-breaks
#8
Bert van de Kooij, Fenna J van der Wal, Magdalena B Rother, Pau Creixell, Merula Stout, Wouter Wiegant, Brian A Joughin, Julia Vornberger, Marcel A T M van Vugt, Matthias Altmeyer, Michael B Yaffe, Haico van Attikum
Homologous Recombination (HR) is a high-fidelity repair mechanism of DNA Double-Strand Breaks (DSBs), which are induced by irradiation, genotoxic chemicals or physiological DNA damaging processes. DSBs are also generated as intermediates during the repair of interstrand crosslinks (ICLs). In this context, the Fanconi anemia (FA) core complex, which is effectively recruited to ICLs, promotes HR-mediated DSB-repair. However, whether the FA core complex also promotes HR at ICL-independent DSBs remains controversial...
September 6, 2023: bioRxiv
https://read.qxmd.com/read/37615925/effects-of-the-major-formaldehyde-catalyzer-adh5-on-phenotypes-of-fanconi-anemia-zebrafish-model
#9
JOURNAL ARTICLE
Anfeng Mu, Zimu Cao, Denggao Huang, Hiroshi Hosokawa, Shingo Maegawa, Minoru Takata
BACKGROUND: Fanconi anemia (FA) is a devastating hereditary disorder for which we desperately need a novel therapeutic strategy. It is caused by mutations in one of at least 22 genes in the FA pathway and is characterized by developmental abnormalities, bone marrow failure, and cancer predisposition. The FA pathway is required for the efficient repair of damaged DNA, including interstrand cross-links (ICL). Recent studies indicate formaldehyde as an ultimate endogenous cause of DNA damage in FA pathophysiology...
August 24, 2023: Molecular Biology Reports
https://read.qxmd.com/read/37429071/anti-ube2t-antibody-a-novel-biomarker-of-progressive-fibrosing-interstitial-lung-disease
#10
JOURNAL ARTICLE
Mari Ujike-Hikichi, Yasuhiro Gon, Takashi Ooki, Tomoko Morisawa, Kenji Mizumura, Yutaka Kozu, Hisato Hiranuma, Yoshiko Nakagawa, Tetsuo Shimizu, Shuichiro Maruoka
BACKGROUND: Anti-fibrotic therapy has demonstrated efficacy against progressive-fibrosing interstitial lung disease (PF-ILD); therefore, identifying disease behavior before progression has become a priority. As autoimmunity is implicated in the pathogenesis of various ILDs, this study explored circulating biomarkers that could predict the chronic progressive behavior of ILDs. METHODS: A single-center retrospective cohort study was conducted. Circulating autoantibodies in patients with ILD were screened using microarray analysis to identify candidate biomarkers...
September 2023: Respiratory Investigation
https://read.qxmd.com/read/37373211/-usp15-usp7-axis-and-ube2t-differential-expression-may-predict-pathogenesis-and-poor-prognosis-in-de-novo-myelodysplastic-neoplasm
#11
JOURNAL ARTICLE
Luiz Gustavo Almeida de Carvalho, Tatiana Takahasi Komoto, Daniel Antunes Moreno, João Vitor Caetano Goes, Roberta Taiane Germano de Oliveira, Mayara Magna de Lima Melo, Mariela Estefany Gislene Vera Roa, Paola Gyuliane Gonçalves, Carlos Victor Montefusco-Pereira, Ronald Feitosa Pinheiro, Howard Lopes Ribeiro Junior
The aim of this study was to evaluate the expression of USP7 , USP15 , UBE2O , and UBE2T genes in Myelodysplastic neoplasm (MDS) to identify possible targets of ubiquitination and deubiquitination in MDS pathobiology. To achieve this, eight datasets from the Gene Expression Omnibus (GEO) database were integrated, and the expression relationship of these genes was analyzed in 1092 MDS patients and healthy controls. Our results showed that UBE2O , UBE2T , and USP7 were upregulated in MDS patients compared with healthy individuals, but only in mononucleated cells collected from bone marrow samples ( p < 0...
June 13, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37298108/lncrna-h19-regulates-breast-cancer-dna-damage-response-and-sensitivity-to-parp-inhibitors-via-binding-to-ilf2
#12
JOURNAL ARTICLE
Junsong Zhao, Junchao Xu, Mingming Wu, Wei Wang, Miaomiao Wang, Leiyan Yang, Huayong Cai, Qiao Xu, Ceshi Chen, Peter E Lobie, Tao Zhu, Xinghua Han
Although DNA damage repair plays a critical role in cancer chemotherapy, the function of lncRNAs in this process remains largely unclear. In this study, in silico screening identified H19 as an lncRNA that potentially plays a role in DNA damage response and sensitivity to PARP inhibitors. Increased expression of H19 is correlated with disease progression and with a poor prognosis in breast cancer. In breast cancer cells, forced expression of H19 promotes DNA damage repair and resistance to PARP inhibition, whereas H19 depletion diminishes DNA damage repair and increases sensitivity to PARP inhibitors...
May 23, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37181827/ube2t-promotes-temozolomide-resistance-of-glioblastoma-through-regulating-the-wnt-%C3%AE-catenin-signaling-pathway
#13
JOURNAL ARTICLE
Yang Wang, Ge Gao, Xiangpin Wei, Yang Zhang, Jian Yu
PURPOSE: Patients with glioblastoma (GBM) have poor prognosis and limited therapeutic options, largely because of chemoresistance to temozolomide (TMZ) treatment. Ubiquitin conjugating enzyme E2 T (UBE2T) plays a key role in regulating the malignancy of various tumors, including GBM; however, its role in TMZ resistance of GBM has not been elucidated. The purpose of this study was to clarify the role of UBE2T in mediating TMZ resistance and investigate the specific underlying mechanism...
2023: Drug Design, Development and Therapy
https://read.qxmd.com/read/36928776/ube2t-resolves-transcription-replication-conflicts-and-protects-common-fragile-sites-in-primordial-germ-cells
#14
JOURNAL ARTICLE
Yongze Yu, Weiwei Xu, Canxin Wen, Simin Zhao, Guangyu Li, Ran Liu, Zi-Jiang Chen, Yingying Qin, Jinlong Ma, Yajuan Yang, Shidou Zhao
The proper development of primordial germ cells (PGCs) is an essential prerequisite for gametogenesis and mammalian fertility. The Fanconi anemia (FA) pathway functions in maintaining the development of PGCs. FANCT/UBE2T serves as an E2 ubiquitin-conjugating enzyme that ubiquitylates the FANCD2-FANCI complex to activate the FA pathway, but its role in the development of PGCs is not clear. In this study, we found that Ube2t knockout mice showed defects in PGC proliferation, leading to severe loss of germ cells after birth...
March 16, 2023: Cellular and Molecular Life Sciences: CMLS
https://read.qxmd.com/read/36913306/correction-ube2t-knockdown-inhibits-gastric-cancer-progression
#15
Changjiang Luo, Yunyi Yao, Zeyuan Yu, Huinian Zhou, Lingyun Guo, Junqiang Zhang, Hongtai Cao, Genyuan Zhang, Yumin Li, Zuoyi Jiao
No abstract text is available yet for this article.
March 11, 2023: Oncotarget
https://read.qxmd.com/read/36910645/identification-and-validation-of-a-novel-ubiquitination-related-gene-ube2t-in-ewing-s-sarcoma
#16
JOURNAL ARTICLE
Guoxin Qu, Yuanchun Xu, Ye Qu, Jinchao Qiu, Guosheng Chen, Nannan Zhao, Jin Deng
BACKGROUND: Ewing's sarcoma (ES) is one of the most prevalent malignant bone tumors worldwide. However, the molecular mechanisms of the genes and signaling pathways of ES are still not well sufficiently comprehended. To identify candidate genes involved in the development and progression of ES, the study screened for key genes and biological pathways related to ES using bioinformatics methods. METHODS: The GSE45544 and GSE17618 microarray datasets were downloaded from the Gene Expression Omnibus (GEO) database...
2023: Frontiers in Oncology
https://read.qxmd.com/read/36852074/hsa_circ_0072309-is-a-prognostic-biomarker-and-is-correlated-with-immune-infiltration-in-gastric-cancer
#17
JOURNAL ARTICLE
Bei-Bei Xu, Yi Huang, En-Dian Zheng, Jing-Ya Wang, Chen-Jing Zhang, Xiao-Ge Geng, Ya-Nan Wang, Wen-Sheng Pan
BACKGROUND: Hsa_circ_0072309 has been identified as a tumor suppressor in several carcinomas. However, its precise role in gastric cancer (GC) remains largely unknown. This study was aimed to explore the precise role of Hsa_circ_0072309 in GC. METHODS: The transcriptional and clinical data of stomach adenocarcinoma were downloaded using the University of California SantaCruz (UCSC) Xena browser. The circular RNA (circRNA) datasets were obtained from the Gene Expression Omnibus (GEO) database...
February 2023: Heliyon
https://read.qxmd.com/read/36842710/targeting-ube2t-potentiates-gemcitabine-efficacy-in-pancreatic%C3%A2-cancer-by-regulating-pyrimidine-metabolism-and-replication-stress
#18
JOURNAL ARTICLE
Xiangyan Jiang, Yong Ma, Tao Wang, Huinian Zhou, Keshen Wang, Wengui Shi, Long Qin, Junhong Guan, Lianshun Li, Bo Long, Jianli Wang, Xiaoying Guan, Huili Ye, Jing Yang, Zeyuan Yu, Zuoyi Jiao
BACKGROUND & AIMS: Although small patient subsets benefit from current targeted strategies or immunotherapy, gemcitabine remains the first-line drug for pancreatic cancer (PC) treatment. However, gemcitabine resistance is widespread and compromises long-term survival. Here, we identified ubiquitin-conjugating enzyme E2T (UBE2T) as a potential therapeutic target to combat gemcitabine resistance in PC. METHODS: Proteomics and metabolomics were combined to examine the effect of UBE2T on pyrimidine metabolism remodeling...
June 2023: Gastroenterology
https://read.qxmd.com/read/36825587/diverse-roles-of-ube2t-in-cancer-review
#19
JOURNAL ARTICLE
Nengqian Ma, Zhangzhan Li, Jingting Yan, Xianrong Liu, Liyan He, Ruijie Xie, Xianzhou Lu
As a leading cause of mortalities worldwide, cancer results from accumulation of both genetic and epigenetic alterations. Disruption of epigenetic regulation in cancer, particularly aberrant ubiquitination, has drawn increasing interest in recent years. The present study aimed to review the roles of ubiquitin‑conjugating enzyme E2 T (UBE2T) and its associated pathways in the pathogenesis of pan‑cancer, and the development of small‑molecule modulators to regulate ubiquitination for treatment strategies...
April 2023: Oncology Reports
https://read.qxmd.com/read/36786134/identification-of-drug-targets-and-agents-associated-with-hepatocellular-carcinoma-through-integrated-bioinformatics-analysis
#20
JOURNAL ARTICLE
Md Alim Hossen, Md Selim Reza, Md Harun-Or-Roshid, Md Ariful Islam, Mst Ayesha Siddika, Md Nurul Haque Mollah
BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death globally. The mechanisms underlying the development of HCC are mostly unknown till now. OBJECTIVE: The main goal of this study was to identify potential drug target proteins and agents for the treatment of HCC. METHODS: The publicly available three independent mRNA expression profile datasets were downloaded from the NCBI-GEO database to explore common differentially expressed genes (cDEGs) between HCC and control samples using the Statistical LIMMA approach...
February 14, 2023: Current Cancer Drug Targets
keyword
keyword
105176
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.